search
Back to results

Awake Prone Positioning for Non-intubated COVID-19 Patients

Primary Purpose

Prone Position, Coronavirus Disease 2019, Oxygenation

Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
prone position group
Sponsored by
Damanhour University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Prone Position

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Aged 18-75 years old
  2. Awake non-intubated spontaneously breathing patients
  3. Confirmed diagnosis of severe COVID-19; manifesting as dyspnea with respiratory rate ≥ 30 breaths/min, pulse rate ≥ 100 beats/min, oxygen saturation ≤93%, or partial pressure of arterial oxygen (PaO2) to fraction of inspired oxygen (FiO2) ratio ≤ 150 mmHg.
  4. Positive RT-PCR for SARS-CoV-2 from analysis of nasopharyngeal, oropharyngeal swab, or tracheal secretion specimens and with chest X-ray showing bilateral infiltrations or chest computerized tomographic (CT) images showing exudation or consolidation.
  5. Requiring supplemental oxygen (nasal cannula, non-invasive CPAP, non-rebreathing face mask)
  6. Capable of adopting a prone posture independently.

Exclusion Criteria:

The presence of any of the following will mean patients are ineligible:

  1. life-threatening arrhythmias
  2. Hemodynamic instability (defined as mean arterial pressure [MAP] < 65mm Hg and use of vasopressors to achieve MAP > 65 mm Hg)
  3. Altered mental status, intracranial hypertension
  4. Facial injuries
  5. Spine or pelvic fractures
  6. Recent abdominal surgery
  7. Pregnancy
  8. Altered mental status and patients needing invasive ventilation.

Sites / Locations

  • Faculty of nursing

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control group (conventional care)

Intervention group (prone position group)

Arm Description

Patients randomized to this arm will receive the conventional positioning interventions provided by the critical care nurses, which will not include self-prone positioning.

Patients randomized to this arm will receive self-prone positioning.

Outcomes

Primary Outcome Measures

Oxygenation index
arterial oxygen pressure/fractional inspired oxygen PaO2/FiO2 ratio mmHg.
SpO2
Peripheral oxygen saturation
ROX index
combination of the ratio of oxygen saturation measured by pulse oximetry to fraction of inspired ox¬ygen and respiratory rate ([SpO2/FiO2]/respiratory rate)
PaO2mmHg
Partial pressure of oxygen within arterial blood
PCO2mmHg
The partial pressure of carbon dioxide within arterial blood
SaO2
Oxygen saturation (SaO2) is a measurement of the percentage of how much hemoglobin is saturated with oxygen.
pH
The acidity or alkalinity of blood.
Respiratory Rate (RR) (bpm)
the number of breaths a person takes per minute.
Heart Rate (HR) (bpm)
is the the speed of the heartbeat measured by the number of contractions (beats) of the heart per minute (bpm)
Blood Pressure (BP) mmHg
is the the pressure of circulating blood against the walls of blood vessels.
Positive response to prone positioning
defined as a 10% increase in PaO2/FiO2 ratio or 10% decrease in respiratory rate

Secondary Outcome Measures

Prone position adverse events
respiratory distress, dyspnea, use of accessory respiratory muscles, oxygen desaturation SpO2≤70%, hypotension SBP≤90 mmHg, vomiting, aspiration, musculoskeletal pain, discomfort, facial edema, pressure ulcers and accidental withdrawal of catheters, tubes and/or drainages.

Full Information

First Posted
February 15, 2021
Last Updated
January 29, 2022
Sponsor
Damanhour University
search

1. Study Identification

Unique Protocol Identification Number
NCT04760561
Brief Title
Awake Prone Positioning for Non-intubated COVID-19 Patients
Official Title
Effects of Awake Prone Positioning on Oxygenation and Physiological Outcomes in Non-intubated COVID-19 Patients
Study Type
Interventional

2. Study Status

Record Verification Date
January 2022
Overall Recruitment Status
Completed
Study Start Date
February 20, 2021 (Actual)
Primary Completion Date
March 20, 2021 (Actual)
Study Completion Date
April 20, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Damanhour University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The burden of coronavirus disease 2019 (COVID-19) pandemic is still on a rising course making a great stress on medical resources throughout the world. Although most of COVID-19 patients require non-invasive oxygenation and ventilation, rapid progression to hypoxemic respiratory failure and then acute respiratory distress syndrome (ARDS) can occur in some COVID19 patients due to prolonged or unaddressed hypoxia. Prone positioning is a common supportive ventilation strategy to improve oxygenation in critically ill patients with ARDS. Recent studies point out the potential benefits of using this strategy for non-intubated awake COVID 19 patients who are hypoxic. Despite several retrospective cohort studies have been conducted to identify impact of the prone positioning in awake non-intubated COVID-19 patients, experimental studies are very rare. This study therefore aims to evaluate the effects of self-prone positioning on oxygenation and physiological outcomes among awake-non intubated patients with COVID-19.
Detailed Description
A randomised controlled trial design will be adopted to achieve the aim of the current study. In this study 82 adult patients of either sex with a confirmed diagnosis of COVID-19 will be recruited from general intensive care unit of the chest hospital (affiliated to the Ministry of Health) in Damanhour city, El Beheira Governorate, Egypt. Patients will be enrolled in the current study if they meet study inclusion criteria. The eligible patients will be randomly assigned into two groups (control and intervention group) 41 patients in each. The control group will receive the standard management of COVID-19 patients according to the Egyptian Ministry of health guidelines. The standard management includes supplemental oxygen or non-invasive continuous positive airway pressure (CPAP), antivirals, antibiotics, anticoagulants and glucocorticoids, as necessary, based on the patients' clinical condition. Patients in the control group will be subjected to the conventional positioning interventions provided by the critical care nurses, which will not include self-prone positioning. Patients in the intervention group will receive self-prone positioning and standard management of COVID-19 patients. All patients in both groups (control and intervention) will be monitored continuously by cardiac monitoring with oxygen saturation (SpO2) during the study period. The demographic and baseline clinical data of all eligible patients will collected and recorded using the study tool. Each patient in the intervention group will be helped into the prone position and encouraged to stay in the prone position as long as tolerated (at least 1 hour). The prone positioning consists of placing the patient on his or her stomach with the head on the side. Self-prone position will be performed 45 minutes up to 1 hour after meals to avoid gastrointestinal side effects. The patient will be maintained in prone position until the patient becomes too tired and uncomfortable to keep that position. If patients will asked to regain the supine position before the 1 hour period was complete, patient's prone position will be considered unfeasible and the reason will be reported. Patients who required invasive mechanical ventilation at any time point will be intubated and excluded from the study. The effect of patients' positioning on oxygenation and physiological parameters will be collected and recorded. These parameters include vital signs (respiratory rate, systolic blood pressure, diastolic blood pressure and heart rate), SpO2, oxygenation index (PaO2/FiO2 ratio), ROX index (combination of the ratio of oxygen saturation measured by pulse oximetry to fraction of inspired oxygen and respiratory rate [SpO2/FiO2]/respiratory rate) and arterial blood gases parameters (pH, PaO2mmHg, PaCO2mmHg and SaO2). These parameters will be recorded before and after positioning (immediately before, after 10 minutes and after 1hour). Data of secondary outcomes of self-prone positioning will also be collected and recorded.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prone Position, Coronavirus Disease 2019, Oxygenation

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Experimental research design
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
82 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control group (conventional care)
Arm Type
No Intervention
Arm Description
Patients randomized to this arm will receive the conventional positioning interventions provided by the critical care nurses, which will not include self-prone positioning.
Arm Title
Intervention group (prone position group)
Arm Type
Experimental
Arm Description
Patients randomized to this arm will receive self-prone positioning.
Intervention Type
Procedure
Intervention Name(s)
prone position group
Intervention Description
Patients randomized to this arm will receive self-prone positioning. Each patient in the intervention group will be helped into the prone position and encouraged to stay in the prone position as long as tolerated (at least 1 hour). The prone positioning consists of placing the patient on his or her stomach with the head on the side. Self-prone position will be performed 45 minutes up to 1 hour after meals to avoid gastrointestinal side effects. The patient will be maintained in prone position until the patient becomes too tired and uncomfortable to keep that position. If patients will asked to regain the supine position before the 1 hour period was complete, patient's prone position will be considered unfeasible and the reason will be reported. Patients who required invasive mechanical ventilation at any time point will be intubated and excluded from the study.
Primary Outcome Measure Information:
Title
Oxygenation index
Description
arterial oxygen pressure/fractional inspired oxygen PaO2/FiO2 ratio mmHg.
Time Frame
Change in the value immediately before, after 10 minutes and after 1hour of patient positioning
Title
SpO2
Description
Peripheral oxygen saturation
Time Frame
Change in the value immediately before, after 10 minutes and after 1hour of patient positioning.
Title
ROX index
Description
combination of the ratio of oxygen saturation measured by pulse oximetry to fraction of inspired ox¬ygen and respiratory rate ([SpO2/FiO2]/respiratory rate)
Time Frame
Change in the value immediately before and after 1hour of patient positioning.
Title
PaO2mmHg
Description
Partial pressure of oxygen within arterial blood
Time Frame
change in the value immediately before and after 1hour of patient positioning.
Title
PCO2mmHg
Description
The partial pressure of carbon dioxide within arterial blood
Time Frame
change in the value immediately before and after 1hour of patient positioning.
Title
SaO2
Description
Oxygen saturation (SaO2) is a measurement of the percentage of how much hemoglobin is saturated with oxygen.
Time Frame
change in the value immediately before and after 1hour of patient positioning.
Title
pH
Description
The acidity or alkalinity of blood.
Time Frame
change in the value immediately before and after 1hour of patient positioning.
Title
Respiratory Rate (RR) (bpm)
Description
the number of breaths a person takes per minute.
Time Frame
change in the value immediately before, after 10 minutes and after 1hour of patient positioning.
Title
Heart Rate (HR) (bpm)
Description
is the the speed of the heartbeat measured by the number of contractions (beats) of the heart per minute (bpm)
Time Frame
change in the value immediately before, after 10 minutes and after 1hour of patient positioning.
Title
Blood Pressure (BP) mmHg
Description
is the the pressure of circulating blood against the walls of blood vessels.
Time Frame
change in the value immediately before, after 10 minutes and after 1hour of patient positioning.
Title
Positive response to prone positioning
Description
defined as a 10% increase in PaO2/FiO2 ratio or 10% decrease in respiratory rate
Time Frame
Time Frame: change in the value of PaO2/FiO2 ratio or respiratory rate after 1hour of patient positioning
Secondary Outcome Measure Information:
Title
Prone position adverse events
Description
respiratory distress, dyspnea, use of accessory respiratory muscles, oxygen desaturation SpO2≤70%, hypotension SBP≤90 mmHg, vomiting, aspiration, musculoskeletal pain, discomfort, facial edema, pressure ulcers and accidental withdrawal of catheters, tubes and/or drainages.
Time Frame
appearance of events from 10 minutes after patient positioning up to 3hours after patient positioning..

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Aged 18-75 years old Awake non-intubated spontaneously breathing patients Confirmed diagnosis of severe COVID-19; manifesting as dyspnea with respiratory rate ≥ 30 breaths/min, pulse rate ≥ 100 beats/min, oxygen saturation ≤93%, or partial pressure of arterial oxygen (PaO2) to fraction of inspired oxygen (FiO2) ratio ≤ 150 mmHg. Positive RT-PCR for SARS-CoV-2 from analysis of nasopharyngeal, oropharyngeal swab, or tracheal secretion specimens and with chest X-ray showing bilateral infiltrations or chest computerized tomographic (CT) images showing exudation or consolidation. Requiring supplemental oxygen (nasal cannula, non-invasive CPAP, non-rebreathing face mask) Capable of adopting a prone posture independently. Exclusion Criteria: The presence of any of the following will mean patients are ineligible: life-threatening arrhythmias Hemodynamic instability (defined as mean arterial pressure [MAP] < 65mm Hg and use of vasopressors to achieve MAP > 65 mm Hg) Altered mental status, intracranial hypertension Facial injuries Spine or pelvic fractures Recent abdominal surgery Pregnancy Altered mental status and patients needing invasive ventilation.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sahar Y Othman, A/P.
Organizational Affiliation
Faculty of Nursing, Damanhour University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Alaa M Mohamed, Lect.
Organizational Affiliation
Faculty of Nursing, Damanhour University
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Ahmed M El-Menshawy, Lect.
Organizational Affiliation
University of Alexandria
Official's Role
Study Director
Facility Information:
Facility Name
Faculty of nursing
City
Alexandria
ZIP/Postal Code
02225585888
Country
Egypt

12. IPD Sharing Statement

Citations:
PubMed Identifier
33341885
Citation
Binda F, Marelli F, Galazzi A, Pascuzzo R, Adamini I, Laquintana D. Nursing Management of Prone Positioning in Patients With COVID-19. Crit Care Nurse. 2021 Apr 1;41(2):27-35. doi: 10.4037/ccn2020222.
Results Reference
background
PubMed Identifier
33309507
Citation
Dubosh NM, Wong ML, Grossestreuer AV, Loo YK, Sanchez LD, Chiu D, Leventhal EL, Ilg A, Donnino MW. Early, awake proning in emergency department patients with COVID-19. Am J Emerg Med. 2021 Aug;46:640-645. doi: 10.1016/j.ajem.2020.11.074. Epub 2020 Dec 3.
Results Reference
background
PubMed Identifier
32741521
Citation
Flynn Makic MB. Prone Position of Patients With COVID-19 and Acute Respiratory Distress Syndrome. J Perianesth Nurs. 2020 Aug;35(4):437-438. doi: 10.1016/j.jopan.2020.05.008. Epub 2020 May 30. No abstract available.
Results Reference
background
PubMed Identifier
32803468
Citation
Solverson K, Weatherald J, Parhar KKS. Tolerability and safety of awake prone positioning COVID-19 patients with severe hypoxemic respiratory failure. Can J Anaesth. 2021 Jan;68(1):64-70. doi: 10.1007/s12630-020-01787-1. Epub 2020 Aug 14.
Results Reference
background
PubMed Identifier
32455107
Citation
Sztajnbok J, Maselli-Schoueri JH, Cunha de Resende Brasil LM, Farias de Sousa L, Cordeiro CM, Sansao Borges LM, Malaque CMSA. Prone positioning to improve oxygenation and relieve respiratory symptoms in awake, spontaneously breathing non-intubated patients with COVID-19 pneumonia. Respir Med Case Rep. 2020;30:101096. doi: 10.1016/j.rmcr.2020.101096. Epub 2020 May 19.
Results Reference
background
PubMed Identifier
32861885
Citation
Cotton S, Zawaydeh Q, LeBlanc S, Husain A, Malhotra A. Proning during covid-19: Challenges and solutions. Heart Lung. 2020 Nov-Dec;49(6):686-687. doi: 10.1016/j.hrtlng.2020.08.006. Epub 2020 Aug 19.
Results Reference
background

Learn more about this trial

Awake Prone Positioning for Non-intubated COVID-19 Patients

We'll reach out to this number within 24 hrs